feed,title,long_url,short_url
SeekingAlpha,FDA accepts Myovant application for relugolix for uterine fibroids,https://seekingalpha.com/news/3606213,
SeekingAlpha,Goldman boosts S&P 500 year-end target by 20% on falling risk premium,https://seekingalpha.com/news/3606212,
SeekingAlpha,Accolade: Still Very Interesting,https://seekingalpha.com/article/4369144,
SeekingAlpha,"CureVac's Impressive Debut, And Other News: The Good, Bad And Ugly Of Biopharma",https://seekingalpha.com/article/4369143,
SeekingAlpha,"SZC: Revisiting This Fund's Continued Transformation, Still A Buy",https://seekingalpha.com/article/4369145,
